Genome Foundation - Due diligence report

A 360° intelligence report on Genome Foundation: trust score, financial health, credit view, compliance, directors, growth and distress sign…

2004-06-09 Hyderabad, Telangana Active Unlisted Active Compliant
Share
View plans
GF Genome Foundation
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Genome Foundation — 360° Intelligence Report

Generated from MCA filings & public records
76/100
Trust Score
Low Risk

Genome Foundation is assessed as Low Risk with a Trust Score of 76/100. Genome Foundation is an active private not for profit company incorporated in 2004, operating in the Life Sciences sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 02 Jul 2026 from the latest processed filings. Genome Foundation snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
76/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
35/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
05

Director Intelligence

Stability score: 35/100
NameDIN / PANDesignationAppointedTenureDIN status
KOSARAJU RAJESWARA RAO 01234567 Director 01/04/2018 6 yrs Approved
BHUPATIRAJU SOMARAJU 01234567 Director 01/04/2018 6 yrs Approved
APPA RAO PODILE 01234567 Director 01/04/2018 6 yrs Approved
VEERABHADRA RAO ARRVAPALLI 01234567 Director 01/04/2018 6 yrs Approved
VEERA VENKATA SATYA GADICHARLA KANAKA BHUSHANAM 01234567 Director 01/04/2018 6 yrs Approved
VEERAYYA CHOWDARY KOSARAJU 01234567 Director 01/04/2018 6 yrs Approved
POORNA CHANDRA GANDHI KAZA 01234567 Director 01/04/2018 6 yrs Approved
PARIPLAVI MOKKAPATI 01234567 Director 01/04/2018 6 yrs Approved
DEEP KARAN REDDY ADLA 01234567 Director 01/04/2018 6 yrs Approved
DASARI PRASADA RAO 01234567 Director 01/04/2018 6 yrs Approved
REDDANNA PALLU 01234567 Director 01/04/2018 6 yrs Approved
  • 11 directors on the board.
  • KOSARAJU RAJESWARA RAO has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • 4 director exits in 3 years - high churn.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Key managerial personnel: POORNA CHANDRA GANDHI KAZA (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 85 · Distress 65
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Latest year revenue grew 2.1x.
Asset base grew 24% - capacity expansion.
Operating for 22+ years.
Distress signals & risk flags
Losses deepening year-on-year.
3 director exits within 2 years.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence82/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment73/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view78/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
24 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
27 Sep 2024
Director appointed
BHUPATIRAJU SOMARAJU (Director)
Director appointed
VEERA VENKATA SATYA GADICHARLA KANAKA BHUSHANAM (Director)
Director appointed
DEEP KARAN REDDY ADLA (Director)
Director appointed
DASARI PRASADA RAO (Director)
Director appointed
REDDANNA PALLU (Director)
23 Sep 2024
Director ceased
MANOHAR RAO DAGGU
Director ceased
NARENDRA NATH KHANNA
Director ceased
APARNA KAJA
27 Apr 2024
Director ceased
CHAKRAVARTHI RANGARAJAN
29 Sep 2022
Director ceased
APPA RAO PODILE
Director ceased
VEERAYYA CHOWDARY KOSARAJU
Director ceased
PARIPLAVI MOKKAPATI
02 Apr 2022
Director appointed
APPA RAO PODILE (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Debt-to-equity stands at 1.42 - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
11 active director(s) / partner(s); review board churn before relying on management continuity.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Rupak Consultants Private Limited U02423MP1991PTC006512 Indore, Madhya Pradesh, India
Aashray - Promotion Of Social Enterprises Foundation U74120GJ2014NPL080297 Ahmedabad, Gujarat, India
Arogyam Medisoft U74999WB2016PTC216188 New Town, West Bengal, India
Anviva Innotech Private Limited U74999PN2019PTC183940 Pune, Maharashtra, India
Synthera U33111PN2015PTC155498 Pune, Maharashtra, India
Transcribeglass U72900DL2019PTC344334 New Delhi, Delhi, India
Docterz Health-Tech Labs Private Limited U74999MH2020PTC337711 Andheri (East), Maharashtra, India
Omicsgen Lifesciences U74999KL2017PTC050248 Kanayannur, Kerala, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Genome Foundation before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Genome Foundation: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 85/100, margin trends, ownership structure and peer set for Genome Foundation - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 76/100, distress signals and MSME payment-delay disclosures - know whether Genome Foundation pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Genome Foundation - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Genome Foundation an active company?

Genome Foundation has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Genome Foundation financially healthy?

Genome Foundation has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.

Should I do business with Genome Foundation?

Its overall Trust Score is 76/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Genome Foundation?

See the directors and ownership sections above for board and shareholding detail. 11 active director(s) are on record.

Does Genome Foundation have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Genome Foundation up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Genome Foundation?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.